Endotoxin deactivation by transient acidification

Melina M. Ribeiro, Xiumin Xu, Dagmar Klein, Norma S Kenyon, Camillo Ricordi, Maria Sueli S Felipe, Ricardo Pastori

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Recombinant proteins are an important tool for research and therapeutic applications. Therapeutic proteins have been delivered to several cell types and tissues and might be used to improve the outcome of the cell transplantation. Recombinant proteins are propagated in bacteria, which will contaminate them with the lypopolysacharide endotoxin found in the outer bacterial membrane. Endotoxin could interfere with in vitro biological assays and is the major pathological factor, which must be removed or inactivated before in vivo administration. Here we describe a one-step protocol in which the endotoxin activity on recombinant proteins is remarkably reduced by transient exposure to acidic conditions. Maximum endotoxin deactivation occurs at acidic pH below their respective isoelectric point (pI). This method does not require additional protein purification or separation of the protein from the endotoxin fraction. The endotoxin level was measured both in vitro and in vivo. For in vitro assessment we have utilized Limulus Amebocyte Lysate method for in vivo the pyrogenic test. We have tested the above-mentioned method with five different recombinant proteins, including a monoclonal antibody clone 5c8 against CD154 produced by hybridomas. More than 99% of endotoxin was deactivated in all of the proteins; the recovery of the protein after deactivation varied between maximum 72.9% and minimum 46.8%. The anti-CD154 clone 5c8 activity remained unchanged as verified by the measurement of binding capability to activated lymphocytes. Furthermore, the effectiveness of this method was not significantly altered by urea, commonly used in protein purification. This procedure provides a simple and cost-efficient way to reduce the endotoxin activity in antibodies and recombinant proteins.

Original languageEnglish
Pages (from-to)1047-1054
Number of pages8
JournalCell Transplantation
Volume19
Issue number8
DOIs
StatePublished - Nov 22 2010

Fingerprint

Acidification
Recombinant proteins
Endotoxins
Proteins
Recombinant Proteins
Purification
Monoclonal antibodies
Lymphocytes
Clone Cells
Therapeutic Human Experimentation
Antibodies
Urea
Horseshoe Crabs
Assays
Cell Transplantation
Bacteria
Isoelectric Point
Hybridomas
Biological Assay
Tissue

Keywords

  • Endotoxin
  • Lypopolysaccharide
  • Pyrogen
  • Recombinant protein

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Endotoxin deactivation by transient acidification. / Ribeiro, Melina M.; Xu, Xiumin; Klein, Dagmar; Kenyon, Norma S; Ricordi, Camillo; Felipe, Maria Sueli S; Pastori, Ricardo.

In: Cell Transplantation, Vol. 19, No. 8, 22.11.2010, p. 1047-1054.

Research output: Contribution to journalArticle

Ribeiro, Melina M. ; Xu, Xiumin ; Klein, Dagmar ; Kenyon, Norma S ; Ricordi, Camillo ; Felipe, Maria Sueli S ; Pastori, Ricardo. / Endotoxin deactivation by transient acidification. In: Cell Transplantation. 2010 ; Vol. 19, No. 8. pp. 1047-1054.
@article{95f43f7c924a4526aa3526ae2fcd7a83,
title = "Endotoxin deactivation by transient acidification",
abstract = "Recombinant proteins are an important tool for research and therapeutic applications. Therapeutic proteins have been delivered to several cell types and tissues and might be used to improve the outcome of the cell transplantation. Recombinant proteins are propagated in bacteria, which will contaminate them with the lypopolysacharide endotoxin found in the outer bacterial membrane. Endotoxin could interfere with in vitro biological assays and is the major pathological factor, which must be removed or inactivated before in vivo administration. Here we describe a one-step protocol in which the endotoxin activity on recombinant proteins is remarkably reduced by transient exposure to acidic conditions. Maximum endotoxin deactivation occurs at acidic pH below their respective isoelectric point (pI). This method does not require additional protein purification or separation of the protein from the endotoxin fraction. The endotoxin level was measured both in vitro and in vivo. For in vitro assessment we have utilized Limulus Amebocyte Lysate method for in vivo the pyrogenic test. We have tested the above-mentioned method with five different recombinant proteins, including a monoclonal antibody clone 5c8 against CD154 produced by hybridomas. More than 99{\%} of endotoxin was deactivated in all of the proteins; the recovery of the protein after deactivation varied between maximum 72.9{\%} and minimum 46.8{\%}. The anti-CD154 clone 5c8 activity remained unchanged as verified by the measurement of binding capability to activated lymphocytes. Furthermore, the effectiveness of this method was not significantly altered by urea, commonly used in protein purification. This procedure provides a simple and cost-efficient way to reduce the endotoxin activity in antibodies and recombinant proteins.",
keywords = "Endotoxin, Lypopolysaccharide, Pyrogen, Recombinant protein",
author = "Ribeiro, {Melina M.} and Xiumin Xu and Dagmar Klein and Kenyon, {Norma S} and Camillo Ricordi and Felipe, {Maria Sueli S} and Ricardo Pastori",
year = "2010",
month = "11",
day = "22",
doi = "10.3727/096368910X500643",
language = "English",
volume = "19",
pages = "1047--1054",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "8",

}

TY - JOUR

T1 - Endotoxin deactivation by transient acidification

AU - Ribeiro, Melina M.

AU - Xu, Xiumin

AU - Klein, Dagmar

AU - Kenyon, Norma S

AU - Ricordi, Camillo

AU - Felipe, Maria Sueli S

AU - Pastori, Ricardo

PY - 2010/11/22

Y1 - 2010/11/22

N2 - Recombinant proteins are an important tool for research and therapeutic applications. Therapeutic proteins have been delivered to several cell types and tissues and might be used to improve the outcome of the cell transplantation. Recombinant proteins are propagated in bacteria, which will contaminate them with the lypopolysacharide endotoxin found in the outer bacterial membrane. Endotoxin could interfere with in vitro biological assays and is the major pathological factor, which must be removed or inactivated before in vivo administration. Here we describe a one-step protocol in which the endotoxin activity on recombinant proteins is remarkably reduced by transient exposure to acidic conditions. Maximum endotoxin deactivation occurs at acidic pH below their respective isoelectric point (pI). This method does not require additional protein purification or separation of the protein from the endotoxin fraction. The endotoxin level was measured both in vitro and in vivo. For in vitro assessment we have utilized Limulus Amebocyte Lysate method for in vivo the pyrogenic test. We have tested the above-mentioned method with five different recombinant proteins, including a monoclonal antibody clone 5c8 against CD154 produced by hybridomas. More than 99% of endotoxin was deactivated in all of the proteins; the recovery of the protein after deactivation varied between maximum 72.9% and minimum 46.8%. The anti-CD154 clone 5c8 activity remained unchanged as verified by the measurement of binding capability to activated lymphocytes. Furthermore, the effectiveness of this method was not significantly altered by urea, commonly used in protein purification. This procedure provides a simple and cost-efficient way to reduce the endotoxin activity in antibodies and recombinant proteins.

AB - Recombinant proteins are an important tool for research and therapeutic applications. Therapeutic proteins have been delivered to several cell types and tissues and might be used to improve the outcome of the cell transplantation. Recombinant proteins are propagated in bacteria, which will contaminate them with the lypopolysacharide endotoxin found in the outer bacterial membrane. Endotoxin could interfere with in vitro biological assays and is the major pathological factor, which must be removed or inactivated before in vivo administration. Here we describe a one-step protocol in which the endotoxin activity on recombinant proteins is remarkably reduced by transient exposure to acidic conditions. Maximum endotoxin deactivation occurs at acidic pH below their respective isoelectric point (pI). This method does not require additional protein purification or separation of the protein from the endotoxin fraction. The endotoxin level was measured both in vitro and in vivo. For in vitro assessment we have utilized Limulus Amebocyte Lysate method for in vivo the pyrogenic test. We have tested the above-mentioned method with five different recombinant proteins, including a monoclonal antibody clone 5c8 against CD154 produced by hybridomas. More than 99% of endotoxin was deactivated in all of the proteins; the recovery of the protein after deactivation varied between maximum 72.9% and minimum 46.8%. The anti-CD154 clone 5c8 activity remained unchanged as verified by the measurement of binding capability to activated lymphocytes. Furthermore, the effectiveness of this method was not significantly altered by urea, commonly used in protein purification. This procedure provides a simple and cost-efficient way to reduce the endotoxin activity in antibodies and recombinant proteins.

KW - Endotoxin

KW - Lypopolysaccharide

KW - Pyrogen

KW - Recombinant protein

UR - http://www.scopus.com/inward/record.url?scp=78349233862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349233862&partnerID=8YFLogxK

U2 - 10.3727/096368910X500643

DO - 10.3727/096368910X500643

M3 - Article

C2 - 20412635

AN - SCOPUS:78349233862

VL - 19

SP - 1047

EP - 1054

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 8

ER -